What is the 5-year survival rate after cervical cancer metastasizes to lymph nodes?

The 5-year survival rate of cervical cancer after lymph node metastasis is usually 30-50%, which is specifically related to the degree of tumor differentiation, treatment plan and individual differences.

After lymph node metastasis occurs in cervical cancer, the disease stage usually enters the intermediate and advanced stages. At this time, the spread of cancer cells directly affects the prognosis. Clinical statistics show that the 5-year survival rate of patients who receive standardized comprehensive treatment can reach about 40%. Treatment options mostly use concurrent chemoradiotherapy, such as cisplatin combined with external radiation therapy, and some patients may need additional pelvic lymph node dissection. The degree of tumor differentiation is an important influencing factor, and the prognosis of well-differentiated squamous cell carcinoma is better than that of poorly differentiated adenocarcinoma. Early detection of lymph node metastasis and timely intervention can improve survival rates, such as accurately assessing the extent of metastasis through PET-CT and adjusting treatment strategies. The patient's immune function status will also affect the efficacy, and nutritional support and immune regulation can help improve treatment tolerance. When the number of regional lymph node metastases exceeds 3, the prognosis decreases significantly, and intensive chemotherapy or targeted therapy needs to be considered. Some medical centers use intensity-modulated radiotherapy technology to reduce damage to surrounding organs and improve local control rates.

It is recommended that patients undergo regular gynecological examinations and imaging follow-up, maintain a balanced diet and moderate exercise, and pay attention to preventing infection during treatment. Psychological counseling and family support are crucial to long-term quality of life. You can seek guidance from a professional cancer rehabilitation team.